EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudie

Development and validation of six-parameter laboratory-based prognostic model (APHPBA score) for patients undergoing hepatectomy for hepatitis B virus-related hepatocellular carcinoma

Yi-Fei Liu, Hong Wang, Ya-Hao Zhou, Xin Li, Zu-Chao Du, Zi-Jie Tang, Wen-Long Zhai, Yong-Yi Zeng, Ting-Hao Chen, Yong-Kang Diao, Zi-Chao Tu, Li-Hui Gu und 7 weitere

HPB · 2026

DOI: 10.1016/j.hpb.2026.01.005 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift HPB, 2026. Verfasst von Yi-Fei Liu und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital of Henan University, Kaifeng, Henan, China; Department of Hepatobiliary Surgery, Eastern…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatectomy, Hepatitis B. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, National Natural Science Foundation of China, Shanghai Rising-Star Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: HBV-related HCC shows prognostic heterogeneity not fully captured by current staging. We developed and validated the APHPBA score, a laboratory-based model for patients undergoing curative hepatectomy. METHODS: This multicenter retrospective study included patients who underwent hepatectomy for HBV-related HCC between 2018 and 2023. The APHPBA score incorporated six routine preoperative parameters: alpha-fetoprotein (AFP), protein induced by vitamin K absence-II (PIVKA-II), HBV-DNA, prothrombin time (PT), bilirubin (BIL), and albumin (ALB). Patients were stratified into three stages: Stage I (0-1 point), Stage II (2-3 points), and Stage III (4-6 points). Prognostic performance was compared with conventional systems using Cox regression and time-dependent receiver operating characteristic (ROC) analyses. RESULTS: Among 1100 patients, 36.7 % were Stage I, 48.5 % Stage II, and 14.8 % Stage III. After a median follow-up of 48.0 months, 5-year overall survival was 63.4 %, 43.3 %, and 26.4 % across Stages I-III (P < 0.001). The APHPBA score remained independently associated with overall survival after adjustment for clinicopathologic factors and consistently outperformed established staging systems with higher time-dependent AUCs. CONCLUSION: The APHPBA score provides robust postoperative risk stratification for HBV-related HCC using routinely available laboratory parameters.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHepatectomyHepatitis BHumansRetrospective StudiesFemaleMaleMiddle Agedalpha-FetoproteinsPrognosisHepatitis B virusProthrombin TimeNeoplasm StagingBiomarkersProtein PrecursorsRisk AssessmentBilirubinPredictive Value of TestsDNA, ViralAgedProthrombin

Substanzen

alpha-FetoproteinsBiomarkersProtein PrecursorsBilirubinacarboxyprothrombinDNA, ViralProthrombin

Autor:innen und Institutionen

  • Department of General Surgery, The First Affiliated Hospital of Henan University, Kaifeng, Henan, China; Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, C…
  • Department of General Surgery, Liuyang People's Hospital, Changsha, China.
  • Department of Hepatobiliary Surgery, People's Hospital of Pu'er, Yunnan, China.
  • Department of General Surgery, The First Affiliated Hospital of Henan University, Kaifeng, Henan, China.
  • Department of Hepatobiliary Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
  • Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Förderung

  • Natural Science Foundation of Shanghai Municipality
  • National Natural Science Foundation of China
  • Shanghai Rising-Star Program
  • National Major Science and Technology Projects of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Liu, Y. F., Wang, H., Zhou, Y. H., Li, X., Du, Z. C., Tang, Z. J., Zhai, W. L., Zeng, Y. Y., Chen, T. H., Diao, Y. K., Tu, Z. C., Gu, L. H., Wu, H., Shen, F., Wang, M. D., Wang, L., Wu, F., Yang, T., & Eastern HepatoBiliary Alliance (EHBA) group (2026). Development and validation of six-parameter laboratory-based prognostic model (APHPBA score) for patients undergoing hepatectomy for hepatitis B virus-related hepatocellular carcinoma. HPB. https://doi.org/10.1016/j.hpb.2026.01.005

Vancouver

Liu YF, Wang H, Zhou YH, Li X, Du ZC, Tang ZJ, et al. Development and validation of six-parameter laboratory-based prognostic model (APHPBA score) for patients undergoing hepatectomy for hepatitis B virus-related hepatocellular carcinoma. HPB. 2026. doi:10.1016/j.hpb.2026.01.005

BibTeX
@article{Liu2026,
  author = {Liu, Yi-Fei and Wang, Hong and Zhou, Ya-Hao and Li, Xin and Du, Zu-Chao and Tang, Zi-Jie and Zhai, Wen-Long and Zeng, Yong-Yi and Chen, Ting-Hao and Diao, Yong-Kang and Tu, Zi-Chao and Gu, Li-Hui and Wu, Han and Shen, Feng and Wang, Ming-Da and Wang, Lai and Wu, Fei and Yang, Tian and Eastern HepatoBiliary Alliance (EHBA) group, Eastern HepatoBiliary Alliance (EHBA) group},
  title = {Development and validation of six-parameter laboratory-based prognostic model (APHPBA score) for patients undergoing hepatectomy for hepatitis B virus-related hepatocellular carcinoma},
  journal = {HPB},
  year = {2026},
  doi = {10.1016/j.hpb.2026.01.005}
}
Kostenlos starten →